Coegin Pharma AB (NGM:COEGIN)

Market Cap	106.36M +10.5%
Revenue (ttm)	371.00K
Net Income	-19.70M
EPS	-0.79
Shares Out	28.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,476
Open	n/a
Previous Close	3.760
Day's Range	n/a
52-Week Range	2.890 - 9.520
Beta	0.91
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About Coegin Pharma AB

Coegin Pharma AB, a biotechnology company, engages in developing peptide-based products for hair growth and skin pigmentation in Sweden. The company develops Follicopeptide, a peptide designed to enhance hair growth; and NPP-4, a natural pigmentation peptide 4 works by facilitating the transport of melanin to the skin, mimicking the natural process that occurs during sun exposure or tanning beds. It is also developing FOL026, a drug candidate which is in preclinical trial for the treatment of myocardial infarction; AVX420, a drug candidate whic...

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Employees: 3
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: COEGIN